HB2534 would expand Illinois protections around genetic information in insurance by specifically limiting how life insurers may use genetic testing information. The bill amends the Genetic Information Privacy Act to prohibit insurers from seeking information derived from genetic testing for use in connection with a life insurance policy. It also allows an insurer to consider genetic test results only if the individual voluntarily provides them and the results are favorable to that individual.
The bill further amends the Illinois Insurance Code to require insurers to follow the Genetic Information Privacy Act when amending, delivering, issuing, or renewing life insurance policies, as well as when handling claims, coverage denials, and premium or rate determinations. In effect, it ties life insurance underwriting and administration more directly to the state’s genetic privacy rules and creates an explicit statutory cross-reference for life insurance practices.
Impact
If enacted, HB2534 would strengthen statutory limits on the use of genetic data in life insurance underwriting and claims handling in Illinois. It would add a new Section 224.5 to the Illinois Insurance Code and reinforce existing Genetic Information Privacy Act protections by making them expressly applicable to life insurance policy administration, premium setting, and coverage decisions. The bill would primarily affect life insurers and consumers who have undergone genetic testing, while preserving a narrow exception for voluntarily submitted, favorable results.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be framed as a consumer privacy protection bill with a generally protective posture toward policyholders. Its structure suggests support for limiting insurer access to sensitive genetic information while still allowing consumers to disclose favorable results if they choose. No recorded opposition or formal vote history is available in the provided materials, so there is no documented public sentiment beyond the bill’s pro-privacy design.
Contention
The main policy tension in HB2534 is between genetic privacy and insurer risk assessment. Supporters would likely view the bill as preventing discrimination or coercive use of genetic test results in life insurance, while insurers may be concerned that restricting access to genetic information could limit underwriting tools or affect pricing accuracy. Another point of potential contention is the asymmetry in the bill’s exception: insurers may consider voluntarily submitted results only when they are favorable to the applicant, which could be seen as consumer-friendly but also as a departure from neutral underwriting practices.